New 3-[4-(aryl)piperazin-1-yl]-1(benzo[b]thiophen-3-yl) propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

被引:50
作者
Martínez, J
Pérez, S
Oficialdegui, AM
Heras, B
Orús, L
Villanueva, H
Palop, JA
Roca, J
Mourelle, M
Bosch, A
Del Castillo, JC
Lasheras, B
Tordera, R
del Río, J
Monge, A
机构
[1] Univ Navarra, Dept Med Chem, E-31080 Pamplona, Spain
[2] Univ Navarra, CIFA, E-31080 Pamplona, Spain
[3] Univ Navarra, Dept Pharmacol, E-31080 Pamplona, Spain
[4] Vita Invest SA, Barcelona 08970, Spain
关键词
arylpiperazines; antidepressant; 5-HT1A antagonist; serotonin reuptake inhibitor;
D O I
10.1016/S0223-5234(00)01198-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives were synthesized in an attempt to find a new class of antidepressant drugs with dual activity at 5-HT1A serotonin receptors and serotonin transporter. Title compounds were evaluated for in vitro activity on 5-HT1A receptor and 5-HT transporter. They show high nanomolar affinity for both activities, and in particular, compounds 1-(5-chlorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-1-ol (7) and 1-(5-fluorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl) piperain-1-yl]propan-1-ol (8) show values (nM) of K-i = 30 and 2.3 for 5-HT1A receptors and K-i = 30 and 12 for serotonin transporters, respectively. In GTP gammaS binding assays, compound 8 revealed antagonist properties to 5-HT1A receptors. Such a pharmacological profile could lead to potent antidepressant agents with new dual mechanism of action. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 22 条
[1]   METHYLENEDIOXYMETHAMPHETAMINE INDUCES OPPOSITE CHANGES IN CENTRAL PRESYNAPTIC AND POSTSYNAPTIC 5-HT1A RECEPTORS IN RATS [J].
AGUIRRE, N ;
GALBETE, JL ;
LASHERAS, B ;
DELRIO, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :101-105
[2]   Characterization of 5-HT1A receptor-mediated [35S]GTPγS binding in rat hippocampal membranes [J].
Alper, RH ;
Nelson, DL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 343 (2-3) :303-312
[3]  
ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248
[4]  
ASBERG M, 1986, J CLIN PSYCHIAT, V47, P23
[5]   EFFECTS OF A SELECTIVE 5-HT REUPTAKE BLOCKER, CITALOPRAM, ON THE SENSITIVITY OF 5-HT AUTORECEPTORS - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
CHAPUT, Y ;
DEMONTIGNY, C ;
BLIER, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 333 (04) :342-348
[6]   Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors [J].
Dreshfield, LJ ;
Wong, DT ;
Perry, KW ;
Engleman, EA .
NEUROCHEMICAL RESEARCH, 1996, 21 (05) :557-562
[7]  
Evrard DA, 1999, ANNU REP MED CHEM, V34, P1
[8]   SYNTHESIS OF NEW 4-QUINOLONE-TYPE COMPOUNDS IN THE BENZO[B]THIOPHENE SERIES [J].
FEVRIER, B ;
DUPAS, G ;
BOURGUIGNON, J ;
OUEGUINER, G .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1993, 30 (04) :1085-1088
[9]   INTERACTION BETWEEN A SELECTIVE 5-HT1A RECEPTOR ANTAGONIST AND AN SSRI IN-VIVO - EFFECTS ON 5-HT CELL FIRING AND EXTRACELLULAR 5-HT [J].
GARTSIDE, SE ;
UMBERS, V ;
HAJOS, M ;
SHARP, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) :1064-1070
[10]   IDENTIFICATION OF PRE-SYNAPTIC SEROTONIN AUTORECEPTORS USING A NEW LIGAND - H-3-PAT [J].
GOZLAN, H ;
ELMESTIKAWY, S ;
PICHAT, L ;
GLOWINSKI, J ;
HAMON, M .
NATURE, 1983, 305 (5930) :140-142